The 2nd Japan Medical Affairs Summit, Co-Organized by MAPS, PhRMA and JAPhMed will take place April 22-23, 2024 in Tokyo. We invite you to HELP SHAPE the future of Medical Affairs in Japan as we continue to our quest to greater impact patient outcomes.
Since its opening in 1987, PhRMAʼs Japan office has actively developed various activities on behalf of its member companies in Japan. We promote activities focused on direct dialogue with all concerned parties such as government officials, doctors and other medical staff, media parties and patient organizations. PhRMA cooperates with the Japan Pharmaceutical Federation, the Japan Pharmaceutical Industry Association, and the European Pharmaceutical Federation to develop activities.
JAPhMed has more than 50 years of history in developing “pharmaceutical medicine” in Japan which is defined as a medical specialty concerned with the discovery, development, evaluation, licensing and monitoring of medicines and the medical aspects of their marketing. Based on our mission: “To promote Pharmaceutical Medicine by enhancing the knowledge, expertise and skills of pharmaceutical professionals and physicians, thus leading to the availability and appropriate use of medicines for the benefit of patients and the society.” JAPhMed operates as the Japanese affiliate of the International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine (IFAPP).
The Medical Affairs Professional Society (MAPS) is the premier non-profit global Medical Affairs organization FOR Medical Affairs professionals BY Medical Affairs professionals across all different levels of experience/specialty. Together with over 10,500 Medical Affairs members from 300+ companies globally, MAPS is transforming the Medical Affairs profession to increase its value to patients, HCPs, industry and society.
MAPS transforms Medical Affairs organizations and Medical Affairs professionals globally by: speaking as the single voice of the Medical Affairs profession; defining the current and future practice of Medical Affairs; being the global community for Medical Affairs professionals; and leveraging collective thought leadership to train the next generation of Medical Affairs leaders.
Nihonbashi Life Science HUB
1-5-5, Nihonbashi-muromachi, Chuo-ku
Tokyo 103-0022
Simultaneous Translation for English/Japanese is available for the General Session on April 22. Please note that the Career Development Workshop on April 23 will be held in Japanese and will not have translation service provided. Please refer to the Brochure for more information.
8:30 – 8:50: Registration & Networking
8:50 – 9:00: Opening Remarks
9:00 – 9:30: Fireside Chat: The Critical Impact in MA of Cross-Functional Alignment
9:30 – 10:30: Keynote Session: Impact of Digital on Medical Affairs
10:30 – 11:00: Networking Break & Exhibits
11:00 – 13:00: Digital Transformation and the Role of Medical Affairs
13:00 – 14:00: Networking Lunch
14:00 – 15:30: Patient Centricity & Continuing Medical Education
15:30 – 16:00: Networking Break & Exhibits
16:00 – 18:25: How To establish the MSL in Japan
18:25 – 18:30: Day 1 Closing Remarks
18:30 – 19:30: Networking Cocktail Reception
8:30 – 9:00: Registration & Networking
9:00 – 11:00: Career Development Workshop
11:00 – 11:30: Networking Break & Exhibits
11:30 – 12:30: Career Development Workshop
12:30: Summit Concludes
8:30 – 9:00: Registration & Networking
9:00 – 9:30: Opening & Speech on MA 2030 Vision
9:30 – 9:50: Talent Management – Results Sharing
9:50 – 10:30: Talent Management – Breakout Discussion
10:30 – 11:00: Networking Break & Coffee
11:00 – 11:20: Medical Activity & Impact Measurement – Art of Leveraging Analytics
11:20 – 12:00: Medical Activity & Impact Measurement – Breakout Discussion
12:00 – 12:50: Networking Lunch & Wrap – Up
*The Medical Heads’ Roundtable is an invitation-only session for Medical Heads from BioPharma Companies from Japan and global. If you are interested in attending, please send an email to jon.liong@lycheegroup.com
All Pricing is in US Dollars
Chief Medical Officer & Vice Chairperson, Head of Medical Affairs Committee
Aculys / JAPhMed
Associate Vice President Scientific Advisor & Medical Affairs Committee Chair
MSD K.K. / PhRMA
Senior Manager, MSLO Excellence, MO, Medical Affairs Division/MSL Training Curriculum Lead
Alexion Pharma / JAPhMed
MSL / Medical Affairs Committee Working Group 3, Leader
MSD K.K / PhRMA
Associate Vice President-Medical, Diabetes Products Japan Drug Development & Medical Affairs/ Vice-Chair, Medical Affairs Committee
Eli Lilly Japan K.K. / PhRMA
Director, Scientific Innovation Lead / Working Group 1 Leader, PhRMA Medical Affairs Committee
Gilead Sciences K.K.
Senior Medical Director, Immunology/PH/Neuroscience, Medical Affairs Japan
Janssen Pharmaceutical K. K.
Chief Medical Officer & Vice Chairperson, Head of Medical Affairs Committee
Aculys / JAPhMed
Associate Vice President Scientific Advisor & Medical Affairs Committee Chair
MSD K.K. / PhRMA
Senior Manager, MSLO Excellence, MO, Medical Affairs Division/MSL Training Curriculum Lead
Alexion Pharma / JAPhMed
MSL / Medical Affairs Committee Working Group 3, Leader
MSD K.K / PhRMA
Associate Vice President-Medical, Diabetes Products Japan Drug Development & Medical Affairs/ Vice-Chair, Medical Affairs Committee
Eli Lilly Japan K.K. / PhRMA
Chief Medical Officer International Developed Markets, ACCORD/ GCAP
Pfizer
Corporate Officer, Medical Affairs, Executive Medical Director
Amgen K.K.
Corporate Officer, Chief Medical Officer
Novartis Pharma K.K.
Director of Teikyo Academic Research Center (TARC) & Regent
Teikyo University
Director, Health Care Compliance
Janssen Pharmaceutical K. K
Senior Director, Head of Oncology, Medical Affairs Japan
Gilead Sciences K.K.
Senior Vice President, Head of Medical Affairs
Astellas Pharma Inc.
Head of Physician, Department of Medical Oncology Head of Strategic Promotion Section, Department of International Medical and Advanced Care Staff Physician, Rare Cancer Center
National Cancer Center Hospital
Professor, Department of Health Policy Management
Nippon Medical Hospital
Director of MSL, Medical Affairs Dept. Integrated Disease Care Division / Vice Chairperson of Medical Affairs Expert Committee
Shionogi & Co. Ltd. / Japan Pharmaceutical Manufacturers Association (JPMA)
Associate Director, Medical Digital Solution, Medical Affairs Capabilities, Japan Drug Development & Medical Affairs
Eli Lilly Japan K.K.
Executive Director, Japan Medical Affairs Capabilities
MSD K.K.
Professor, Division of Social Pharmacy, Center for Social Pharmacy and Pharmaceutical Care Sciences, Faculty of Pharmacy
Keio University
Oncology Medical Affairs Hematology Lead
Pfizer Japan Inc.
Senior Manager, Medical Lead (Immunology), Innovative Medicine Medical, Japan Medical
Bristol-Myers Squibb K.K.
Email pcampa@medicalaffairs.org to secure a sponsorship.
MAPSはメディカルアフェアーズ組織の進化・発展を目的として運営されている世界的な学会です
ジャパンサミット2024
MAPS、PhRMA、JAPhMed が共催するジャパン メディカル アフェアーズ サミットが、2024 年 4 月 22 ～ 23 日に東京で開催されます。患者の転帰について。
PhRMAの日本オフィスは1987年1月の開設以来、在日加盟企業を代表し様々な活動を積極的に展開しています。行政、医療政策担当者、医師をはじめとする医療従事者、報道関係者、そして患者団体等、関係するすべての団体と直接対話を重視した活動を推進しています。PhRMAは日本製薬団体連合会、日本製薬工業協会、欧州製薬団体連合会と協力して活動を展開しています。
一般財団法人 日本製薬医学会は製薬医学に関わる業務、すなわち、新薬の開発、承認、医薬品の販売、管理・安全対策等において活躍されている産官学のメンバーを中心とした団体です。本学会は1967年1月のMD会を出発点として、既に50年余りの歴史を有しており、2009 年4 月より一般財団法人 日本製薬医学会（The Japanese Association of Pharmaceutical Medicine : JAPhMed）として法人化し現在に至っております。
本学会では、“製薬医学専門家の知識、専門性およびスキルの向上を通して製薬医学を推進し、患者と社会のベネフィットのために医薬品へのアクセスと適正使用へと導くことにある” をミッションとして掲げておりますJAPhMedは国際製薬医学会（IFAPP）の日本支部として運営されています。
The Medical Affairs Professional Society (MAPS) is the premier non-profit global Medical Affairs organization FOR Medical Affairs professionals BY Medical Affairs professionals across all different levels of experience/specialty. Together with over 10,500 Medical Affairs members from 300+ companies globally, MAPS is transforming the Medical Affairs profession to increase its value to patients, HCPs, industry and society.
MAPS transforms Medical Affairs organizations and Medical Affairs professionals globally by: speaking as the single voice of the Medical Affairs profession; defining the current and future practice of Medical Affairs; being the global community for Medical Affairs professionals; and leveraging collective thought leadership to train the next generation of Medical Affairs leaders.
〒103-0022 東京都中央区日本橋室町１丁目５−5 室町ちばぎん三井ビルディング8階
TEL: 03-6214-3086
4 月22 日に開催される一般セッションでは日英同時通訳が利用可能です 4 月23 日に開催されるワークショップは日本語で実施されます。日英同時
通訳の提供はございませんこと予めご了承ください。
8:30 – 8:50: Registration & Networking
8:50 – 9:00: Opening Remarks
9:00 – 9:30: Fireside Chat: The Critical Impact in MA of Cross-Functional Alignment
9:30 – 10:30: Keynote Session: Impact of Digital on Medical Affairs
10:30 – 11:00: Networking Break & Exhibits
11:00 – 13:00: Digital Transformation and the Role of Medical Affairs
13:00 – 14:00: Networking Lunch
14:00 – 15:30: Patient Centricity & Continuing Medical Education
15:30 – 16:00: Networking Break & Exhibits
16:00 – 18:25: How To establish the MSL in Japan
18:25 – 18:30: Day 1 Closing Remarks
18:30 – 19:30: Networking Cocktail Reception
8:30 – 9:00: Registration & Networking
9:00 – 11:00: Career Development Workshop
11:00 – 11:30: Networking Break & Exhibits
11:30 – 12:30: Career Development Workshop
12:30: Summit Concludes
4月23日- Medical Heads’ Roundtable
8:30 – 9:00: Registration & Networking
9:00 – 9:30: Opening & Speech on MA 2030 Vision
9:30 – 9:50: Talent Management – Results Sharing
9:50 – 10:30: Talent Management – Breakout Discussion
10:30 – 11:00: Networking Break & Coffee
11:00 – 11:20: Medical Activity & Impact Measurement – Art of Leveraging Analytics
11:20 – 12:00: Medical Activity & Impact Measurement – Breakout Discussion
12:00 – 12:50: Networking Lunch & Wrap – Up
*The Medical Heads’ Roundtable is an invitation-only session for Medical Heads from BioPharma Companies from Japan and global. If you are interested in attending, please send an email to jon.liong@lycheegroup.com
価格はアメリカドルで表示されています
アソシエイトバイスプレジデント サイエンティフィック・アドバイザー/ メディカルアフェアーズ委員会 委員長
MSD株式会社/ 米国研究製薬 工業協会
シニアマネージャー、MSLエクセレンス / MSLトレーニングカリキュラムタスク リード
アレクシオンファーマ合同会社/ 日本製薬医学会
アソシエイトバイスプレジデン ト、メディカル / メディカルア フェアーズ委員会 副委員長
日本イーライリリー株式会社 / 米国研究製薬工業協会
メディカルアフェアーズ サイエンティフィックイノベーションリード ディレクター/PhRMA メディカルアフェアーズ委員会 Working Group 1 リーダー
ギリアド・サイエンシズ株式会社
アソシエイトバイスプレジデント サイエンティフィック・アドバイザー/ メディカルアフェアーズ委員会 委員長
MSD株式会社/ 米国研究製薬 工業協会
シニアマネージャー、MSLエクセレンス / MSLトレーニングカリキュラムタスク リード
アレクシオンファーマ合同会社/ 日本製薬医学会
アソシエイトバイスプレジデン ト、メディカル / メディカルア フェアーズ委員会 副委員長
日本イーライリリー株式会社 / 米国研究製薬工業協会
ヘルスケア戦略本部 メディカルアフェアーズ部 ＭSLグループ長 / 医薬品評価委員会 メディカルアフェアーズ部会 副部会長
塩野義製薬株式会社 / 日本製薬工業協会
メディカルアフェアーズ統括本部 メディカルアフェアーズケーパビリティズ メディカルデジタルソリューション アソシエイトディレクター
日本イーライリリー株式会社
お問い合わせはpcampa@medicalaffairs.org までご連絡下さい。
